Medpace

Forecast & Rating13 analysts currently cover Medpace, with about 15.4% giving a positive rating — meaning they expect the stock to rise. The average price target is $581.83, about 1.2% downside from the current price of $588.91. Price targets range from $370.00 to $692.00 — a wide spread, showing clear disagreement over just how much Medpace can rise. Historically, about 94.5% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Medpace's outlook. Data as of Jul 28, 2026; for reference only and not investment advice.